Schoder H - Search Results

1

Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma.

Moskowitz CH, Matasar MJ, Zelenetz AD, Nimer SD, Gerecitano J, Hamlin P, Horwitz S, Moskowitz AJ, Noy A, Palomba L, Perales MA, Portlock C, Straus D, Maragulia JC, Schoder H, Yahalom J. Moskowitz CH, et al. Among authors: schoder h. Blood. 2012 Feb 16;119(7):1665-70. doi: 10.1182/blood-2011-10-388058. Epub 2011 Dec 19. Blood. 2012. PMID: 22184409 Free PMC article. Clinical Trial.

2

Positron emission imaging of head and neck cancer, including thyroid carcinoma.

Schöder H, Yeung HW. Schöder H, et al. Semin Nucl Med. 2004 Jul;34(3):180-97. doi: 10.1053/j.semnuclmed.2004.03.004. Semin Nucl Med. 2004. PMID: 15202100 Review.

3

Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET.

Pandit-Taskar N, Schöder H, Gonen M, Larson SM, Yeung HW. Pandit-Taskar N, et al. Among authors: schoder h. AJR Am J Roentgenol. 2004 Oct;183(4):1143-7. doi: 10.2214/ajr.183.4.1831143. AJR Am J Roentgenol. 2004. PMID: 15385321

4

Melanoma metastasis to the testis demonstrated with FDG PET/CT.

Weng LJ, Schöder H. Weng LJ, et al. Among authors: schoder h. Clin Nucl Med. 2004 Dec;29(12):811-2. doi: 10.1097/00003072-200412000-00012. Clin Nucl Med. 2004. PMID: 15545888 No abstract available.

5

Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

Schöder H, Noy A, Gönen M, Weng L, Green D, Erdi YE, Larson SM, Yeung HW. Schöder H, et al. J Clin Oncol. 2005 Jul 20;23(21):4643-51. doi: 10.1200/JCO.2005.12.072. Epub 2005 Apr 18. J Clin Oncol. 2005. PMID: 15837966

6

18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

Schöder H, Carlson DL, Kraus DH, Stambuk HE, Gönen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM, Wong RJ. Schöder H, et al. J Nucl Med. 2006 May;47(5):755-62. J Nucl Med. 2006. PMID: 16644744 Free article. Clinical Trial.

7

Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.

Pryma DA, Schöder H, Gönen M, Robbins RJ, Larson SM, Yeung HW. Pryma DA, et al. Among authors: schoder h. J Nucl Med. 2006 Aug;47(8):1260-6. J Nucl Med. 2006. PMID: 16883003 Free article. Clinical Trial.

8

FDG-PET detected thyroid incidentalomas: need for further investigation?

Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR. Are C, et al. Among authors: schoder h. Ann Surg Oncol. 2007 Jan;14(1):239-47. doi: 10.1245/s10434-006-9181-y. Epub 2006 Oct 6. Ann Surg Oncol. 2007. PMID: 17024553

9

Thymic extension in the superior mediastinum in patients with thymic hyperplasia: potential cause of false-positive findings on 18F-FDG PET/CT.

Smith CS, Schöder H, Yeung HW. Smith CS, et al. Among authors: schoder h. AJR Am J Roentgenol. 2007 Jun;188(6):1716-21. doi: 10.2214/AJR.06.0552. AJR Am J Roentgenol. 2007. PMID: 17515398

10

Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.

Ong SC, Schöder H, Lee NY, Patel SG, Carlson D, Fury M, Pfister DG, Shah JP, Larson SM, Kraus DH. Ong SC, et al. Among authors: schoder h. J Nucl Med. 2008 Apr;49(4):532-40. doi: 10.2967/jnumed.107.044792. Epub 2008 Mar 14. J Nucl Med. 2008. PMID: 18344440 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters